Either way dilution is going to be minimal,
Authorized shares are only 950 million shares the last I checked and outstanding is sitting around 360 million shares. Which for a otc stinky penny play the share structure is in great shape compared to majority of the otc.
This being a otc penny stock, share count won’t effect the share price much if at all.
There’s tons of eyes on this and waiting to jump in and that’s not counting the individual brokerage firms that can’t get in until the share price is higher.
So in short, massive dilution will never happen.
Also don’t forget isopet, granted it might be a little longer before we see any significant revenue from it, but it’s very possible to see decent revenue later this year.